NEUROCRINE BIOSCIENCES INC Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three
NEUROCRINE BIOSCIENCES INC (NBIX) had Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three of $23.30 million as of 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Notes › Commitment and Contingencies › Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary · last filed 2024-10-30
- 2024-09-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three $23.30M.
- 2024-06-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three $23.30M.
| Period end | Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three |
|---|---|
| 2024-09-30 | $23.30M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $23.30M 10-Q · filed 2024-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |